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ABSTRACT  
This study explored the experiences of  young people and their caregivers of having adherence 
to inhaled corticosteroids assessed through an electronic monitoring device. These devices are 
increasingly being used for assessing medication adherence, yet there is little information about 
the patient's experience of these tools. Semi-structured interviews were conducted with eight 
young people with severe asthma, aged 11-15, who were electronically monitored as part of 
their care and with their caregivers. Interviews were analysed using thematic analysis. Three 
themes were identified: “they were trying to help me get better”, “checking up and catching out” 
and “who is responsible?” The themes highlighted differences in priorities between participant 
groups, the impact of monitoring on the healthcare relationship, and the dilemma of transferring 
responsibility for asthma management to young people. The findings suggest it is important for 
healthcare professionals to engage in shared decision-making with patients when introducing 
electronic monitoring devices.  
  
Introduction  
Asthma is the most common chronic health condition in children and is believed to be the 
leading preventable cause of morbidity, mortality and healthcare cost worldwide (Heaney and 
Horne, 2012). Inhaled corticosteroids [ICS] are the mainstay of treatment for most patients with 
asthma (Hedlin, de Benedictis and Bush, 2012). Taken regularly, ICS decrease airway 
inflammation, reducing the number of asthma attacks, hospitalisations and asthma related 
mortality (Fong and Levin, 2007). However, some children and young people experience 
ongoing and frequent symptoms and exacerbations of asthma despite being prescribed high 
doses of ICS (Bracken et al., 2009). This population, often described as having “problematic 
severe asthma” [PSA], are estimated to make up around 5% of the childhood asthma population 
(Lang et al., 2008). Poor adherence to ICS is viewed as an important contributor in PSA and a 
variety of methods to assess adherence have been developed and evaluated such as 
prescription refill rate, canister weight and self-report (Bender et al., 2000). However, it is 
recognised that the accuracy of existing methods is limited and there is a general consensus 
that better tools need to be developed to support adherence (Bracken et al., 2009).  
Recent research has championed electronic monitoring devices for accurately measuring 
adherence (Burgess, Sly and Devadson, 2011). The electronic monitoring device [EMD] used in 
the current study was attached to the patient’s inhaler. Once attached, sensors detect when the 
device is actuated and record this information. A healthcare professional subsequently 
accesses this information, which shows the patient’s frequency of inhaler use, the times and 
dates of inhaler use and the dose of ICS taken. They can then discuss the information recorded 
on the inhaler with the patient (Burgess et al., 2006). Electronic measures of adherence and 
other variations of telemonitoring equipment have been extensively evaluated in asthma as well 
as a range of other chronic health conditions (Spaulding et al. 2012). Smith, Elkin and Partridge 
(2009) have called for research to consider whether telemonitoring in respiratory care 
“empowers the patient to self manage their condition” or leads to a “dependence upon advice 
received back in response to technology-based monitoring” (p.162). However, the literature 
exploring this is limited and mixed in its findings, with research suggesting that whilst 
telemonitoring tools can increase the sense of responsibility an individual has for monitoring 
their own health and self-caring, they may do so in a way that maintains a reliance on the 
healthcare system (Fairbrother et al., 2013, Seto et al., 2012). These issues are of particular 
relevance when considering the use of telemonitoring equipment with young people, who are at 
or approaching a stage in their lives where a desire for independence and a rejection of adult 
authority become important (Erikson, 1968). Moreover, young people are growing up in a world 
in which they will have significant experience of surveillance and sharing personal information 
via social media (Lenhart et al. 2010). These factors could either result in them being more wary 
of additional sources of surveillance or more accepting of them. Burgess, Sly and Devadason 
(2010) suggested that giving children and young people with asthma positive feedback on their 
adherence levels increased their use of preventive medication and benefitted their healthcare 
relationships. However, McNicholl and Heaney (2013) reported that for some patients overt 
monitoring, even when done sensitively, will feel too confronting and some may resort to trying 
to conceal their data (Simmons at al. 2000). Recent research and guidance in asthma has also 
focused on the need for young people to be supported in taking increasing responsibility for 
controlling their asthma as they approach adulthood (The British Thoracic Society, 2011). 
Riekert and Rand (2002) suggest that the process of telemonitoring could assist families in 
appropriately transferring responsibility of asthma care from parents to adolescents. However, 
no research has exploredthis issue.  
This study aimed to explore the experiences of young people with asthma and their caregivers 
of having their adherence to ICS assessed through an EMD.  
The research questions were:  
How do young people and caregivers experience being assessed through the EMD?  
Does the process of having ICS adherence assessed through the EMD influence experiences of 
taking responsibility for self-care?  
Does the process of being given the EMD influence the relationship between the healthcare 
professional and the young person/caregiver? 
Method  
The study was approved by a University Research Ethics Committee, an NHS Research Ethics 
Committee and the relevant NHS Trust Research and Development Office. Informed 
consent/age appropriate assent was obtained for all participants. It was conducted in a London-
based tertiary service that serves a large population of children with PSA for whom poor 
adherence is a leading cause of sub-optimal control. The EMD is currently offered to all young 
people referred to the service as part of the assessment protocol. These young people have 
long-term asthma and have been using ICS for at least a year.  
Inclusion criteria:  
• Young person aged 11-16 years.  
• Referred with difficult asthma to the paediatric asthma team at the service.  
• Issued with the EMD as part of their clinical care during the study period (July 2014 to 
Jan 2015).  
Caregivers of the young people who met these inclusion criteria and who accompanied their 
child to the hospital were also invited to participate.  
Exclusion Criteria: 
Only those able to understand and speak English were invited to participate in the 
study. It was not anticipated that this would be problematic as most young people 
attending the clinic can  speak English.  
Young people and caregiver dyads were introduced to the study jointly by a healthcare 
professional during a routine clinic appointment where the EMD wasissued . Those who 
expressed an interest were then given an information sheet and verbal consent was sought for 
their details to be shared with the researcher. The researcher then met potential participants to 
tell them more about the study and to confirm that they would like to take part. Semi structured 
interviews were carried out in a private setting in the service and took place following the 
appointment when the EMD was due to be returned (approximately 6-8 weeks after it was 
issued). Each dyad was interviewed separately, with the young person interviewed first and their 
accompanying caregiver second.  Both young person and caregiver were aware of the others’ 
participation. Two sets of young people and their caregivers requested for their interviews to be 
carried out jointly due to their time limitations. Interviews were guided by an interview schedule 
which consisted of several open-ended questions e.g.  What do you think the smart-inhaler is 
for? Can you tell me about any ways the smart-inhaler helps you/or parent take 
care/responsibility for your asthma? Or any ways it makes this harder? Interviews lasted on 
average 27 minutes for the young people and 18 minutes for the caregivers. Interviews were 
audio-recorded and transcribed. Adherence data were not available to the researcher.  
Data were analysed employing Thematic analysis (TA). This followed the guidelines presented 
by Braun and Clarke (2006). A combination of inductive and deductive approaches was 
adopted.  The interviews with caregivers and young people were treated as a single data set 
and themes reflect commonalities across all of them. Attention was paid to similarities and 
differences between the groups.  
Eleven  eligible young people and their caregivers attended the clinic during the recruitment 
period of whom 8 consented to participate.  Five young people were female and 3 were male, 
ranging in age from 11-15,(mean  = 12.86,  SD =  1.57). Caregivers were female and mothers of 
the participating child. The participants were 75% White British and 25% Asian British.   
Results   
Three super-ordinate themes weredeveloped .  
They Were Trying to Help Me Get Better  
This theme concerns the ways in which participants’ beliefs about asthma and their 
understandings of the risks and vulnerabilities it posed influenced their expectations of the 
healthcare relationship and their experience of being given the EMD. Throughout the interviews, 
the descriptions of asthma that were shared portrayed the health condition as a frightening and 
life threatening illness for which frequent hospital admissions and medical treatment were 
required:  
Caregiver: She could be fine one minute and the next minute she could be like wheezing and 
can’t breathe and stuff, she’s ended up in intensive care  
Researcher: So that means you have to go into hospital quite a lot then?  
Caregiver: Now she’s had one of them these err asthma related injections she’s been fine but 
before that the last two years it’s been really, really hard cause we’ve been in hospital once a 
week sometimes twice   
ICS were seen as offering freedom from restrictions linked with asthma and protection from 
some serious consequences of the condition.  
Researcher: Why do you think it helps [taking your inhaler]?  
Young Person: Because I can do more as in when I didn’t have it I tried to do like a mile race or 
round that and I couldn’t but now like the past year when I took it before the race I could do it all  
Caregiver: Yeh I mean cause the more if she doesn’t forget to take it [the inhaler] then I keep 
saying to her you won’t have to come up the hospital as often  
Caregiver: Yeh yeh.... it takes out the need of being in hospital under observation for a while  
Additionally, several of the young people described how the EMD was something introduced to 
“help” them:  
Young Person: They said that they were gonna record me to see if I was taking it cause I 
weren’t really taking it before and they said that they were trying like to help me get better and 
because I wasn’t taking it properly that that I needed to make sure I was taking it to get better 
and cause I weren’t taking it yeh  
Checking Up and Catching Out  
Whilst participants generally accepted the need to use the inhaler regularly and appreciated the 
benefits of doing so there were some concerns about the intrusiveness of the monitoring 
process.  
Several interviewees perceived the EMD as something healthcare professionals use to check 
up on young people and their families:  
Researcher: What do you think the EMD is for?  
Caregiver: To track his use to check up on us  
Researcher: And when you got the EMD what do you think your son thought it was for?  
Caregiver: To check up on him   
Some caregivers questioned the need for monitoring and conveyed a sense of discomfort in 
relation to this process:  
Caregiver: Yeh because one of my big things is that they always question has he had his 
medication and of course he does I can’t imagine him not I know she said last time some kids 
don’t but I can't imagine him not or any child who needs medication not taking it  
Researcher: So what were your views?  
Caregiver: Well to be honest me and my husband’s view is we’re not particularly over-happy 
with it, it’s like their trying to sort of catch you out at cause if it’s like she’s not taking it and I 
administer, I’m on her all the time and you know we do feel a bit, I dunno how to explain it really 
you know, as if they feel well she’s not taking it  
Many participants likened the introduction of the EMD to a process of covert surveillance:  
Researcher: What did you think about that?  
Young Person: Hmm err it was a little bit spyee  
Researcher: A little bit what? 
Young Person: Spyee  
Researcher: A bit spyee! Ah! Why do you think it felt a little bit spyee?  
Young Person: Well because they are checking up to see if I’m taking my inhaler  
The monitoring process also contributed to a sense of mistrust in the healthcare relationship, 
with participants predicting that the information recorded could land young people in trouble, 
with limited opportunities to explain their side of the story:  
Researcher: And how does it feel for you, kind of knowing that they are going to look at them 
[the EMD data] in that way?  
Young Person: It feels scary cause whenever I don’t, whenever I think of taking it but I haven’t 
it’s like oh, whenever your found or someone says you haven’t done this and you plead 
innocence they are always gonna say that they won't believe you cause it’s the results but you 
thi-, you say ok I’d thought I’d taken it but I didn’t know if I had and yeh  
Researcher: And is that different to before?  
Young Person: Well if I didn’t have the EMD it was like oh oh they won't know so yeh I could 
take it then fine but then now it’s like oh if I don’t take it I’ll be in trouble  
Researcher: And how do you think you would have managed that?  
Young Person: I would have explained it but I don’t think like they would believe me sort of thing 
[Researcher: Yeh ok] but I have been [laughs] I have 
Several of the caregiver participants acknowledged that the EMD could aid their own ability to 
monitor their child’s inhaler use:  
Researcher: And what do you think about having it [the EMD] as part of your routine care and to 
look at the graphs with the doctors?  
Caregiver: Maybe it would be good to see you know, we know he takes it in the evening but it 
would be good to see you know when he takes it at the other times when we’re not around  
Who Is Responsible?  
This theme focuses on participants’ accounts of taking responsibility and ownership for their 
asthma and some of the complexities surrounding this process. Tensions were apparent 
between a normative expectation of young people taking increased responsibility for self-care 
as they mature and a perception that the introduction of the EMD acted against this. There was 
also an indication that reliance on the EMD could result in a diminution of use once it was 
withdrawn.  
Throughout the interviews participants shared their own ways of managing asthma and the 
expectation that the young people living with asthma should be the ones responsible for 
managing it:  
Young Person: As I’m older now she tells me it’s my responsibility I’ve gotta remember to take it 
I’ve gotta take part in things and make sure I do things and I’m like yeh  
For some families however, the introduction of the EMD created tensions in the negotiation of 
responsibility, with participants describing how the introduction of the EMD had resulted in 
young people losing their recently acquired responsibility for their inhalers:  
Researcher: Yes and you said earlier that your son usually takes responsibility for his inhaler 
and I wonder during the time you had the EMD did you feel that changed?  
Caregiver: Yeh I guess usually we keep it in like a box with his medication but I thought I’d 
better keep the EMD high up on a shelf because we have babies and I thought they may smash 
it or they’ll think that it’s a computer and press all the buttons and confuse it so where he was 
more independent it removes that say the I’m going to take my inhaler now and my peak flow 
because we keep it with the peak flow in a box and he can just go and get that himself whereas 
now he has to stand on a chair to get it because he’s nearly 13 you want him to have a bit more 
independence and say I’m taking my inhaler because he’s at high school you know he has to do 
things like that on his own so it reversed back to being us, which I don’t think is good at all 
because at his age you want him to be taking responsibility  
Researcher: That is something I am really interested in how it affects this age group in terms of 
them taking responsibility for their inhalers  
Caregiver: Yeh because when he was at primary school they had all his medication for him in a 
case but they said as he moves to high school the nurse was like no he’s got to take 
responsibility so if he goes out his blue inhaler he got to make sure he’s got his blue inhaler and 
then we’ve had to take all that away from him  
Researcher: That’s really interesting as I guess my next question was about whether you think 
there are any ways the EMD helps your son take responsibility?  
Caregiver: No it was the reverse as they were saying it’s so expensive "so expensive don’t 
break it we don’t have many".  
Additionally, it was suggested that some young people were dismissive of data from the EMD, 
indicating that they were unlikely to use it to monitor and alter their behaviour:  
Researcher: Cause do you think with these sorts of things when they're [young people] then 
presented with evidence that they've not taken it, do you think that affects them taking 
responsibility?  
Caregiver: I don't know if you're gonna show em a graph they are just gonna go [shrugs and 
pulls face], you know it's err you know you could probably tell them till you're blue in the face  
For young people where the EMD was viewed as something that could help them take some 
responsibility for taking their ICS regularly, there was a sense that once the EMD was taken 
away and there was no longer anyone checking, their inhaler use would reduce again:  
Researcher: And so you’ve said about this a bit already but can you tell me about any ways the 
EMD helps you or your family to take care or responsibly for asthma?  
Young Person: It would always make me think about taking it if it was on there all the time  
Researcher: So what do you think will happen now that you’re going home without it? 
Young Person:  I’ll try and carry on but I think it’ll slowly go like I just won’t take it properly  
Discussion 
Most participants described asthma as a serious, life-long condition that needs to be managed 
through engaging with a variety of healthcare behaviours and had a broadly positive view about 
using ICS. . Participants recognised that the EMD had been introduced by professionals to 
promote their health, support their self-care and to alleviate some of the negative consequences 
they experienced whilst living with PSA. However, its  use gave rise to several concerns. For the 
young people, participating in activities and developing independence were  priorities. This 
meant there were occasions when they had not used their inhaler and consequently their 
perceptions of the EMD were often coloured by feelings of fear, mistrust and blame, with the 
technology viewed as something that could get them into trouble. They anticipated that their 
explanations for not taking their ICS would not be listened to by healthcare professionals. For 
caregivers, a main priority was for family life to run smoothly, with asthma management 
incorporated into  family routines. Here, the EMD could be perceived as a nuisance due to its 
fragility. In contrast, it was perceived by some as assisting their priorities, such as by helping 
family life to run smoothly by reducing the need for hospital stays. The experience of having 
inhaler usage monitored also had wider implications for young people and their carers. For 
some, particularly those who viewed asthma as a life-threatening illness, monitoring provided a 
sense of reassurance that healthcare professionals were looking after and “helping”. This is 
consistent Fairbrother et al's . (2013) finding  that telemonitoring provided a sense of 
reassurance and support to patients. It also indicates that when participants viewed the EMD as 
part of a standard helping process, the practice of health surveillance was accepted within the 
healthcare relationship. However, for others, there were feelings of suspicion in relation to the 
introduction of the EMD. Several young people thought the EMD had been introduced because 
healthcare professionals did not believe they were using their inhaler, giving rise to feelings of 
mistrust and wariness. Caregivers also reported thinking that the EMD had been introduced 
because healthcare professionals did not believe them as parents. This could create tensions, 
not only in the relationships between the professional and young person, but also in their 
relationships with caregivers. Caregivers' descriptions of hoping to use the EMD to check on 
their child’s adherence for themselves may also be related to this, with caregivers possibly 
wanting to re-establish their position as reliable sources. These descriptions suggest a chain of 
observation, where both young people and caregivers are monitored through health surveillance 
technology while young people may also be monitored by caregivers using the same 
technology. The young person is thus potentially under surveillance from all sides.  
A material consequence of the monitoring process was its effect on the young people’s ability to 
take responsibility for their asthma. Policy, guided by research, has emphasised the importance 
of transferring responsibility for managing asthma from the caregiver to the young person as the 
latter approaches adulthood (The British Thoracic Society, 2011). However, our findings indicate 
that use of the EMD may have a negative effect on this process. Young people were described 
as having lost any recently acquired responsibility for their inhalers. This responsibility was 
transferred back to their caregivers, who became more involved, partly in response to their own 
feelings of having their supervision ability monitored through the EMD. Closely linked with this 
was the way in which the monitoring process impacted on young people’s confidence in being 
responsible for taking their inhalers. Young people described feeling more worried about 
forgetting to take their ICS following the introduction of the EMD and they consequently sought 
reassurance from their caregivers concerning this. The increase in caregiver involvement noted 
above may have contributed to this process. This is not inconsistent with Spaulding et al.'s 
(2012) report that electronic monitoring motivated patients to use their inhalers correctly to avoid 
non-adherence being identified, but it suggests that there is a clear downside to adherence 
motivated by these considerations The fact the some participants in our study suggested that 
once the EMD was taken away and there was no longer anyone checking, their inhaler use 
would reduce again indicates the potential limitations of an externally based locus of control. 
This conflicts with the recent findings of Jochmann et al. (2015) which indicated that the 
introduction of an EMD led to sustained adherence behaviour change (although in this study 
participants did receive feedback on their adherence). However, it does suggest that a more 
phased withdrawal could be beneficial.  
The EMD was experienced by some as a form of health surveillance which undermined young 
people's and caregivers’ confidence in taking responsibility for medication use with potentially 
problematic long-term consequences for disease management. Viewed in this light the EMD 
forms part of wider advances in medical technology that enable clinicians to monitor the degree 
to which patients adhere to treatment regimes and protocols and indeed the increasing use of 
technology to monitor fitness and physiological parameters more generally, such as Fitbit and 
the Apple Watch. Use of such technology has raised important issues linked with privacy and 
autonomy (e.g. Levy, 2014) and connects with more widespread concerns about the 
consequences of surveillance and the negative impact of living in a culture in which surveillance 
in many forms is increasingly common (Ellis, Harper and Tucker, 2013).  
There are some  limitations to the current study. One is the absence of male caregivers from the 
sample. Fathers are under-represented in clinical paediatric research and their perspectives 
may differ (Costigan and Cox, 2001).   Also, participants were interviewed at the appointment 
where they were due to return the EMD, so there was no opportunity to inquire into what 
happened thereafter. This is relevant, as it is possible that many of the fears about the EMD that 
the participant’s shared could have been alleviated at this later appointment.  Future research 
should be prospective in nature and carry out interviews at different stages in the use of EMDs.   
Conclusions 
Introducing EMDs into healthcare can be experienced as a useful support tool for patients when 
perceived as something that is there to improve their health and self-care ability and as reducing 
some of the negative consequences of living with a chronic health condition. However, the 
suspicions of both young people and caregivers need to be explicitly engaged with lest the 
healthcare relationship become imbued with mistrust. Identifying patients’ preferences and 
priorities in relation to treatment decisions is therefore an important step in the process of 
shared decision-making and it is important for healthcare professionals to be aware that there 
may be different priorities for caregivers and young people in relation to management of severe 
asthma.  Considering the use of electronic monitoring tools on a case by case basis, where they 
are used as part of a needs-driven care plan will likely support this process.  
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